Preamble:
In recent years, with the continuous improvement of medical standards, more and more diseases can be effectively treated with drugs. However, at the same time, the high price of drugs has also become a serious problem for the majority of patients. In particular, some common drugs for the treatment of infections are not sold at a high price abroad, but once they enter the domestic market, the price will rise, putting great pressure on the financial burden of patients. What kind of entanglement of interests exists in this, and how can we effectively solve this problem? Next, let's take a closer look at some of the deep-seated problems behind the soaring prices of domestic drugs.
First, the price of domestic drugs has skyrocketed, and the financial burden of patients is heavy
Recently, an incident involving the skyrocketing prices of domestic drugs has attracted widespread attention. It turns out that the price of a drug to treat infections in foreign countries is not high, only a few tens of yuan per box, however, once this drug enters the domestic market, the price has soared directly to thousands of yuan, such a sky-high price of drugs makes many patients prohibitive, and they have to endure a heavy financial burden in the face of the torture of the disease.
Many people are very puzzled about this situation, why is there such a big difference in the price of the same drug in different countries and regions? In fact, there are some very complex reasons behind this. It is understood that the reason why this drug has sky-high prices is mainly because domestic pharmaceutical companies need to purchase APIs from relevant API companies in the production process, and some companies deliberately monopolize the raw material agency rights of drugs in order to make huge profits, so that they can raise the price of the final preparation through sky-high APIs, so as to obtain huge profits.
Second, the monopoly of API companies, the price of domestic drugs has risen repeatedly
In this case, the company that monopolized the agency of raw materials was called Boss Li's company, and this company had a close cooperative relationship with the Shanghai pharmaceutical company, and they could adjust the price of the drug at any time as long as they wanted, but the patients had no choice but to let the price of the drug continue to rise.
In fact, the monopoly of API companies is not a single case, in the mainland pharmaceutical market, such things are not uncommon, and this has directly led to the repeated rise in the price of domestic drugs. In addition, some medical representatives and doctors are also involved, and they get kickbacks and benefits by promoting the lie that "domestic drugs are effective" to patients, so that patients can actively choose to use domestic drugs, so that they can make huge profits from them, and patients are greatly hurt by it.
3. The national regulatory authorities should intervene to strengthen the supervision of the drug market
In response to the problem of soaring prices of domestic drugs, more and more people have begun to question the pharmaceutical market, they believe that there is a great division of interests, and some lawbreakers are behind the scenes, and their behavior not only damages the legitimate rights and interests of patients, but also destroys the fair competition environment of the entire pharmaceutical market.
In order to effectively solve this problem, the relevant state departments have also begun to intervene in the investigation, and have increased the supervision of the pharmaceutical market, requiring all links to operate strictly in accordance with the law, without any illegal acts. In this incident, the regulatory authorities punished four companies in accordance with the law, and the illegal matters involved were also publicly exposed, which undoubtedly gave a very good warning to the society and also made everyone see the necessity of strengthening the supervision of the drug market.
Epilogue:
Drugs are expensive and we can't afford to hurt, and such incidents have once again made people see some deep-seated problems in the medical field, and also made us realize that medical reform is imminent. In the future development, we hope that the country can increase the reform of the medical field, through a series of measures, to solve the stubborn disease of "medicine for medicine", so that patients can really benefit, and also hope that all actors in the society can join hands and work together to contribute to the improvement of the medical environment.